Lower-dose anti-thymocyte globulin effective in aplastic anaemia

Comparison of dosing schedules at two Brisbane hospitals has suggested that a low-dose regimen of anti-thymocyte globulin in patients with aplastic anaemia may be as effective as standard higher doses, and potentially reduce the risk of adverse side effects. Dr Ashleigh Scott and colleagues compared 14 patients treated with 40 mg/kg on days 1 to ...

Already a member?

Login to keep reading.

© 2021 the limbic